Day: June 13, 2023
Sevenstep Launches Talent Acquisition Assessment Service: Talent Unbounded®
BOSTON, June 13, 2023 (GLOBE NEWSWIRE) — Sevenstep, a global talent solutions leader, today announced the launch of Talent Unbounded®, its talent acquisition assessment and consulting service. Based on more than fifteen years of experience meeting hard-to-fill, high-value talent needs for top global enterprises and mid-market organizations, Talent Unbounded provides strategy and expertise to position […]
LeddarTech, a Disruptive Automotive Software Provider, to Become a Public Company Via Business Combination With Prospector Capital Corp.
LeddarTech has the potential to disrupt the markets for Advanced Driver Assistance Systems (“ADAS”) and Autonomous Driving (“AD”) with patented low-level sensor fusion and perception software products. LeddarTech’s unique solution solves current limitations, enabling leading automotive original equipment manufacturers (“OEMs”) and Tier 1-2 suppliers to drive ADAS and AD to new levels of performance, safety […]
LeddarTech, un fournisseur de logiciels pour automobiles hautement innovateurs, deviendra une société publique par le biais d’un regroupement d’entreprises avec Prospector Capital Corp.
LeddarTech a le potentiel de perturber le marché des systèmes avancés d’aide à la conduite (systèmes ADAS) et de conduite autonome (systèmes AD) grâce à des produits logiciels brevetés de fusion bas niveau de capteurs et de perception. La solution unique de LeddarTech résout les limitations actuelles en permettant aux principaux manufacturiers et équipementiers d’automobiles […]
Ascendis Pharma Showcases Its Latest Endocrinology Programs, Data, and Research at ENDO 2023
– Endocrinology clinical development progress and research in growth hormone deficiency, hypoparathyroidism, achondroplasia, and Turner Syndrome will be highlighted – Phase 3 Week 52 data for TransCon™ PTH in adults with hypoparathyroidism selected for oral presentation COPENHAGEN, Denmark, June 13, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it will showcase its latest Endocrinology Rare […]